Endologix Announces Debt Restructuring Addressing 2020 Maturities

Posted in

February 24, 2020 • 2 min read

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders ...

Intersect ENT Reports Fourth Quarter and Full Year 2019 Results

Posted in

February 24, 2020 • 2 min read

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today reported financial results for the fourth quarter and full year ended December 31, 20...

Merit Medical Systems Announces Four Regulatory Approvals

Posted in

February 20, 2020 • 2 min read

SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy...

Adamis Pharmaceuticals Provides Update Regarding ZIMHI

Posted in

February 19, 2020 • 2 min read

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today provided an update on the ZIMHI™ New Drug Application (NDA) resubmission process....